- Home
- ENSC vs IBG Comparison
ENSC vs IBG Comparison
Compare ENSC & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- IBG
- Stock Information
- Founded
- ENSC 2003
- IBG 2018
- Country
- ENSC United States
- IBG Australia
- Employees
- ENSC N/A
- IBG N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- ENSC Health Care
- IBG Consumer Staples
- Exchange
- ENSC Nasdaq
- IBG Nasdaq
- Market Cap
- ENSC 9.0M
- IBG 9.6M
- IPO Year
- ENSC N/A
- IBG 2024
- Fundamental
- Price
- ENSC $6.45
- IBG $0.72
- Analyst Decision
- ENSC
- IBG Strong Buy
- Analyst Count
- ENSC 0
- IBG 1
- Target Price
- ENSC N/A
- IBG N/A
- AVG Volume (30 Days)
- ENSC 63.3K
- IBG 114.9K
- Earning Date
- ENSC 03-14-2025
- IBG 02-15-2025
- Dividend Yield
- ENSC N/A
- IBG N/A
- EPS Growth
- ENSC N/A
- IBG N/A
- EPS
- ENSC N/A
- IBG N/A
- Revenue
- ENSC $4,421,404.00
- IBG $3,147,763.00
- Revenue This Year
- ENSC $89.78
- IBG N/A
- Revenue Next Year
- ENSC N/A
- IBG N/A
- P/E Ratio
- ENSC N/A
- IBG N/A
- Revenue Growth
- ENSC 40.41
- IBG N/A
- 52 Week Low
- ENSC $2.12
- IBG $0.60
- 52 Week High
- ENSC $22.47
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- ENSC 39.92
- IBG N/A
- Support Level
- ENSC $6.61
- IBG N/A
- Resistance Level
- ENSC $7.36
- IBG N/A
- Average True Range (ATR)
- ENSC 0.65
- IBG 0.00
- MACD
- ENSC -0.13
- IBG 0.00
- Stochastic Oscillator
- ENSC 6.32
- IBG 0.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.